Structure Therapeutics的封面图片
Structure Therapeutics

Structure Therapeutics

生物技术研究

South San Francisco,California 7,959 位关注者

Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity.

关于我们

Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.

所属行业
生物技术研究
规模
51-200 人
总部
South San Francisco,California
类型
上市公司
创立
2017
领域
Metabolic Diseases、Cardiovascular Diseases、Pulmonary、Diabetes、Computational Chemistry和Obesity

地点

  • 主要

    601 Gateway Blvd

    Suite 900

    US,California,South San Francisco,94080

    获取路线
  • 11F, Changtai Plaza Building A, Lane 2889 Jinke Road

    CN,China,Shanghai,201203

    获取路线

Structure Therapeutics员工

动态

相似主页

融资